908 Devices (MASS) Shares Outstanding (Weighted Average) (2020 - 2026)
908 Devices (MASS) reported Shares Outstanding (Weighted Average) of $36.8 million for Q1 2026, up 4.05% year-over-year from $35.4 million in Q1 2025, and up 74920.69% quarter-over-quarter from $49078.0 in Q4 2025.
908 Devices (MASS) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $36.8 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $36.8 million, up 4.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.8 million (up 4.05% YoY), and the FY2025 annual result was $49078.0, down 99.86% from the prior year.
- Shares Outstanding (Weighted Average) rose to $36.8 million in Q1 2026 per MASS's latest filing, from $49078.0 in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $36.8 million in Q1 2026 and troughed at $43625.0 in Q1 2023.
- A 5-year average of $23.8 million and a median of $32.2 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Weighted Average) tumbled 99.86% in 2023, then jumped 77418.88% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $31.5 million in 2022, then increased by 2.37% to $32.2 million in 2023, then rose by 5.7% to $34.1 million in 2024, then tumbled by 99.86% to $49078.0 in 2025, then jumped by 74920.69% to $36.8 million in 2026.
- Business Quant data shows MASS's Shares Outstanding (Weighted Average) at $36.8 million in Q1 2026, $49078.0 in Q4 2025, and $36.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 579.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 456.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 385.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 98.20 Mn |
| 10 | 908 Devices | 304.12 Mn | 192.38 Mn | 6.88 Mn | 36.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.82 Mn |
| Dec 31, 2025 | 49,078.00 |
| Sep 30, 2025 | 36.10 Mn |
| Jun 30, 2025 | 35.63 Mn |
| Mar 31, 2025 | 35.39 Mn |
| Dec 31, 2024 | 34.08 Mn |
| Sep 30, 2024 | 33.82 Mn |
| Jun 30, 2024 | 33.39 Mn |
| Mar 31, 2024 | 32.71 Mn |
| Dec 31, 2023 | 32.24 Mn |
| Sep 30, 2023 | 43,625.00 |
| Jun 30, 2023 | 32.20 Mn |
| Mar 31, 2023 | 43,625.00 |
| Dec 31, 2022 | 31.49 Mn |
| Sep 30, 2022 | 92,703.00 |
| Jun 30, 2022 | 92,703.00 |
| Mar 31, 2022 | 31.21 Mn |
| Dec 31, 2021 | 27.96 Mn |
| Sep 30, 2021 | 92,703.00 |
| Jun 30, 2021 | 27.34 Mn |